This website is an international information resource intended for international healthcare professionals outside the United States of America (USA) and the United Kingdom (UK) who are interested in information on the clinical trial investigation of dabigatran etexilate and idarucizumab.
While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that the registration status and approved product labels of dabigatran etexilate and idarucizumab may not be the same in different countries.
This site presents clinical trial data that have been presented at international medical and scientific congresses. The information provided is not country-specific and may vary from the approved label in the country where you are located. Please refer to your local Prescribing Information for full details.
By clicking I accept below you are declaring and confirming that you are a healthcare professional outside the USA and the UK and have read and understood this disclaimer.
Go to US Pradaxa website
for healthcare professionals in the USA
Go to UK Pradaxa website
for healthcare professionals in the UK